Medical Bravo Inc. appoints Dr. Lawrence Tanenbaum as Chairman of its Advisory Clinical Board

Medical Bravo Inc. is pleased to announce the appointment of Dr. Lawrence Tanenbaum as Chairman of Clinical Advisory Board, marking an important step in the company’s continued development and expansion in the United States.

Dr. Tanenbaum is a nationally recognized neuroradiologist and medical imaging technology leader with decades of experience spanning clinical radiology, advanced imaging, healthcare technology and executive leadership.

He has held senior leadership positions at RadNet, including Vice President, Chief Technology Officer and Director of Advanced Imaging. Previously, he served as Associate Professor of Radiology and Director of MRI, CT and Outpatient and Advanced Imaging Development at the Icahn School of Medicine at Mount Sinai.

Throughout his career, Dr. Tanenbaum has worked at the intersection of radiology, technology and clinical operations. His expertise includes MRI, CT, neuroradiology and the adoption of artificial intelligence in medical imaging. He has authored more than 100 scholarly and peer-reviewed publications and delivered close to 2,000 invited lectures worldwide.

As Chairman of the Clinical Advisory Board, Dr. Tanenbaum will play a key role in shaping Medical Bravo Inc.’s clinical innovation and medical imaging technology strategy while supporting the company’s development and expansion in the U.S. market. His appointment brings extensive knowledge of the U.S. radiology market, imaging technology and large-scale clinical operations to Medical Bravo Inc.’s leadership team.

The appointment represents a significant milestone in the company’s U.S. growth strategy and reinforces its commitment to combining clinical expertise, advanced technology and operational excellence.

We are delighted to welcome Dr. Tanenbaum to Medical Bravo Inc. and look forward to working together as we continue to develop our clinical and technology strategy and expand our presence in the United States.